Results from both in vitro and in vivo tumor models indicated that tumor CD147 promoted production of endothelial VEGF soluble isoforms (especially the most angiogenic ones) and their major receptor VEGFR-2 via transcription factor HIF-2α (84). This evidence concerns the gene VEGFA and neoplasm.